Johnson & Johnson 2Q profit jumps on higher sales vs. 2012 quarter hurt by huge charges

NEW BRUNSWICK, N.J. – Johnson & Johnson says its second-quarter profit more than doubled on higher sales of medicines and medical devices

The maker of Tylenol, prescription drugs and medical devices handily beat Wall Street expectation.

New Brunswick, N.J.-based J&J says net income was $3.83 billion, or $1.33 per share, up from $1.41 billion, or 50 cents per share. Last year’s quarter was weighed down by big charges.

Excluding one-time items, net income was $4.29 billion, or $1.48 per share.

Revenue was $17.88 billion, up 8.5 per cent from $16.48 billion a year earlier.

Analysts polled by FactSet were expecting earnings per share of $1.39 and sales of $17.72 billion.

The company raised its profit forecast to $5.40 to $5.47 per share, excluding items. In January, J&J predicted earnings of $5.35 to $5.45 per share.

News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

The Associated Press

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.